is tirzepatide on shortage there a Major GLP-1 Drug Over. Some Patients Aren't Celebrating A pill could solve the – FDA Announced Removal of Tirzepatide

The number of injections and frequency of them will vary from person to person

R., Briggs, W

doi: 10.1007/s004180050228 21 FingerTEKinnamonSC

The result of these changes can include: Flatter or sunken cheeks Prominent or dark under-eye area or tear troughs Deepened folds or creases, especially around the mouth A more pronounced jawline with less midface support Thinning skin that loses its bounce and elasticity A general drawn or tired appearance While some patients embrace these changes as a natural part of aging or weight loss, others feel that their facial appearance no longer reflects how energetic or healthy they feel on the inside

It is a marketing infrastructure story

The SELECT safety analysis found breast cancer rates were marginally lower on semaglutide than placebo, and a 2025 meta-analysis of 50 randomised GLP-1 trials found no increased breast cancer risk